|
肌层浸润性膀胱癌与非肌层浸润性膀胱癌分析
|
Abstract:
膀胱癌是泌尿系统最常见的恶性肿瘤之一,近年来发病率更是不断上升,膀胱癌是威胁中国居民健康的主要恶性肿瘤之一,存在明显的性别、地区和年龄流行差异。中国膀胱癌发病率升高与死亡率呈下降趋势,在临床治疗过程中,更是应该注重分类治疗,个性化治疗,从而改善膀胱癌患者预后及生存期,而膀胱癌从是否达到肌层浸润可分为肌层浸润性膀胱癌及非肌层浸润性膀胱癌,从而分类而来的膀胱癌在发病率、治疗、预后、病理类型等方面都存在一定的差异性,分析两者之间的流行病学、治疗方式、预后等。
Bladder cancer is one of the most common malignant tumors of urinary system. The incidence rate of bladder cancer is increasing in recent years. China’s bladder cancer is one of the major malignant tumors threatening the health of Chinese residents. There are obvious differences in gender, region and age. The incidence rate of bladder cancer in China is decreasing. In clinical treatment, we should pay more attention to the classification therapy and personalized treatment, so as to improve the prognosis and survival time of bladder cancer patients. Bladder cancer can be divided into muscular invasive bladder cancer and non muscle invasive bladder cancer from the muscular infiltration. There are some differences in prognosis and pathological types, so as to analyze the epidemiology, treatment and prognosis between them.
[1] | Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492 |
[2] | Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi?eros, M., Znaor, A., Soerjomataram, I. and Bray, F. (2018) Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer, Lyon. |
[3] | Andersson, K.-E. and Arner, A. (2004) Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology. Physiological Reviews, 84, 935-986. https://doi.org/10.1152/physrev.00038.2003 |
[4] | Wong, M.C., Fung, F.D.H., Leung, C., Cheung, W.W.L., Goggins, W.B. and Ng, A.C.F. (2018) The Global Epidemiology of Bladder Cancer: A Join Point Regression Analysis of Its Incidence and Mortality Trends and Projection. Scientific Reports, 8, Article No. 1129. https://doi.org/10.1038/s41598-018-19199-z |
[5] | 郑荣寿, 孙可欣, 张思维, 曾红梅, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. |
[6] | 李辉章, 郑荣寿, 杜灵彬, 张思维, 朱陈, 魏文强, 赫捷. 中国膀胱癌流行现状与趋势分析[J]. 中华肿瘤杂志, 2021, 43(3): 293-298. |
[7] | Mohammadian, M., Safari, A., Allah Bakeshei, K., et al. (2020) Recent Patterns of Bladder Cancer Incidence and Mortality: A Global Overview. World Cancer Research Journal, 7, e1464. |
[8] | 戴奇山, 何慧婵, 蔡超, 等. 吸烟与中国人膀胱癌相关性的多中心病例对照研究[J]. 中华医学杂志, 2011, 91(34): 2404-2410. |
[9] | Abnet, C.C., Freedman, N.D., Silverman, D.T., et al. (2011) Association between Smoking and Risk of Bladder Cancer among Men and Women. JAMA: The Journal of the American Medical Association, 306, 737-745.
https://doi.org/10.1001/jama.2011.1142 |
[10] | Cumberbatch, M.G., Cox, A., Teare, D., et al. (2015) Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-Analysis. JAMA Oncology, 1, 1282-1290.
https://doi.org/10.1001/jamaoncol.2015.3209 |
[11] | Brennan, P., Bogillot, O., Cordier, S., Greiser, E., Schill, W., Vineis, P., Lopez-Abente, G., Tzonou, A., Chang-Claude, J., Bolm-Audorff, U., Jockel, K.H., Donato, F., Serra, C., Wahrendorf, J., Hours, M., T’Mannetje, A., Kogevinas, M. and Boffetta, P. (2000) Cigarette Smoking and Bladder Cancer in Men: A Pooled Analysis of 11 Case Control Studies. International Journal of Cancer, 86, 289-294.
https://doi.org/10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M |
[12] | Lázaro, M., et al. (2016) SEOM Clinical Guideline for Treatment of Muscle-Invasive and Metastatic Urothelial Bladder Cancer. Clinical & Translational Oncology, 18, 1197-1205. https://doi.org/10.1007/s12094-016-1584-z |
[13] | Gakis, G., et al. (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder. European Urology, 63, 45-57.
https://doi.org/10.1016/j.eururo.2012.08.009 |
[14] | 韩志兴, 赵玉千, 刘庆军, 纪世琪, 程文龙, 张海建, 薛芃. TURBT联合放化疗的三联疗法对局限性肌层浸润性膀胱癌患者保留器官的可行性分析[J]. 肿瘤学杂志, 2019, 25(4): 340-344. |
[15] | Herr, H.W., et al. (2007) Defining Optimal Therapy for Muscle Invasive Bladder Cancer. The Journal of Urology, 177, 437-443. https://doi.org/10.1016/j.juro.2006.09.027 |
[16] | Bateni, Z.H., et al. (2020) National Practice Patterns and Overall Survival after Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. European Urology Oncology, 3, 343-350.
https://doi.org/10.1016/j.euo.2018.11.010 |
[17] | 王刚, 关有良. 肌层浸润性膀胱癌保留膀胱综合治疗的可行性分析[J]. 武警后勤学院学报(医学版), 2020, 29(12): 25-29. |
[18] | 张兴, 樊俊杰, 陈宇航, 王起, 吴开杰, 贺大林. 非肌层浸润性膀胱癌整块切除术后行二次电切意义的Meta分析[J]. 现代泌尿外科杂志, 2021, 26(7): 592-596+622. |
[19] | 黄龙, 陈国俊. 非肌层浸润性膀胱癌手术治疗的研究进展[J]. 健康必读, 2020(28): 250. |
[20] | 李吉昌. 膀胱癌早期症状及预防措施[N]. 大众健康报, 2021-07-29(028). |